Back to Search
BRANDON WILKINSON, DO
DO
Emergency Medicine Physician
NPI: 1780145441Individual
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training Program
Student in an Organized Health Care Education/Training Program
Code: 390200000X
Emergency Medicine PhysicianPrimary
Emergency Medicine
Code: 207P00000X
05123(KY)
Research & Publications (20)
Improved pain, physical functioning and health status in patients with rheumatoid arthritis treated with CP-690,550, an orally active Janus kinase (JAK) inhibitor: results from a randomised, double-blind, placebo-controlled trial.
PMID 19587388·Ann Rheum Dis·2010
3-trial
Probing replacement of pyrophosphate via click chemistry; synthesis of UDP-sugar analogues as potential glycosyl transferase inhibitors.
PMID 19233348·Carbohydr Res·2009
7-preclinical
Synthesis of glucose derivatives modified at the 4-OH as potential chain-terminators of cellulose biosynthesis; herbicidal activity of simple monosaccharide derivatives.
PMID 19262928·Org Biomol Chem·2009
8-other
A novel role for Gtb1p in glucose trimming of N-linked glycans.
PMID 19542522·Glycobiology·2009
8-other
Stereoselective synthesis of beta-arabino glycosyl sulfones as potential inhibitors of mycobacterial cell wall biosynthesis.
PMID 19269629·Carbohydr Res·2009
8-other
Double-blind, placebo-controlled, dose-escalation study to evaluate the pharmacologic effect of CP-690,550 in patients with psoriasis.
PMID 19225543·J Invest Dermatol·2009
3-trial
Genes and enzymes involved in bacterial isoprenoid biosynthesis.
PMID 19318289·Curr Opin Chem Biol·2009
6-review
Combining an EGF-based cancer vaccine with chemotherapy in advanced nonsmall cell lung cancer.
PMID 19307998·J Immunother·2009
3-trial
Glycosylation engineering of spinosyn analogues containing an L-olivose moiety.
PMID 19343260·Org Biomol Chem·2009
7-preclinical
Chapter 14. Biosynthesis of nonribosomal peptide precursors.
PMID 19374990·Methods Enzymol·2009
8-other
The safety and efficacy of a JAK inhibitor in patients with active rheumatoid arthritis: Results of a double-blind, placebo-controlled phase IIa trial of three dosage levels of CP-690,550 versus placebo.
PMID 19565475·Arthritis Rheum·2009
3-trial
sarA inactivation reduces vancomycin-intermediate and ciprofloxacin resistance expression by Staphylococcus aureus.
PMID 19324528·Int J Antimicrob Agents·2009
8-other
A mouse chromosome 4 balancer ENU-mutagenesis screen isolates eleven lethal lines.
PMID 19267930·BMC Genet·2009
4-observational
Engineered biosynthesis of hybrid macrolide polyketides containing D-angolosamine and D-mycaminose moieties.
PMID 18802638·Org Biomol Chem·2008
8-other
Optimizing natural products by biosynthetic engineering: discovery of nonquinone Hsp90 inhibitors.
PMID 18800759·J Med Chem·2008
8-other
Synthesis of Arabino glycosyl triazoles as potential inhibitors of mycobacterial cell wall biosynthesis.
PMID 18926698·Bioorg Med Chem Lett·2008
8-other
Insertional inactivation of branched-chain alpha-keto acid dehydrogenase in Staphylococcus aureus leads to decreased branched-chain membrane fatty acid content and increased susceptibility to certain stresses.
PMID 18689519·Appl Environ Microbiol·2008
7-preclinical
Inhibition of carbonic anhydrases with glycosyltriazole benzene sulfonamides.
PMID 18307288·J Med Chem·2008
8-other
The fusidic acid stimulon of Staphylococcus aureus.
PMID 18786940·J Antimicrob Chemother·2008
4-observational
Genetic changes that correlate with the pine-oil disinfectant-reduced susceptibility mechanism of Staphylococcus aureus.
PMID 19120644·J Appl Microbiol·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3110 MACCORKLE AVE SE
CHARLESTON, WV 25304 - Phone
- (304) 388-7170
Quick Facts
- NPI
- 1780145441
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile